Skip to the answer

Metformin / Pioglitazone Uses, Dosage, Side Effects and Interactions

Brand names
Actoplus Met

Actoplus Met was the first metformin / pioglitazone product the FDA approved, in August 2005. An FDA-approved generic with the same active ingredients is listed.

Actoplus Met XR

Actoplus Met XR came 3 years after Actoplus Met (May 2009) as an extended-release tablet, a form not listed for Actoplus Met. An FDA-approved generic with the same active ingredients is listed.

Metformin / Pioglitazone is a two-medicine tablet used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Aug 30, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About Metformin / PioglitazoneType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Metformin / Pioglitazone in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Metformin / pioglitazone combines two type 2 diabetes medicines in one tablet: metformin cuts the sugar your liver releases, and pioglitazone helps your body respond to its own insulin. It is usually a convenience option for people already taking one or both, and it has been on the U.S. market since about 2005, with FDA-approved generics listed. Most people do fine on it, though metformin can loosen stools early on and pioglitazone often adds some weight and ankle swelling. Its boxed warning covers heart failure and lactic acidosis (a rare, dangerous acid buildup), so get help promptly for rapid weight gain, breathlessness, worsening swelling, or unusual muscle pain, sleepiness and stomach pain.

Key Takeaways From the HelloPharmacist Team

  • Take it with meals, once or twice a day as prescribed, because food softens the stomach upset metformin can cause.
  • Give it several weeks to show its full effect, because pioglitazone lowers blood sugar gradually rather than right away.
  • Expect kidney and liver blood tests before you start and regular kidney checks after, more often if you are 65 or older.
  • Keep alcohol light, and ask about pausing it before contrast-dye scans, surgery, or any stretch when you cannot eat or drink.

How we write and review this content: our editorial policy

FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Metformin / Pioglitazone.

This medicine can cause or worsen heart failure and can cause a rare but life-threatening condition called lactic acidosis.

Heart failure: Pioglitazone can make your body hold fluid. Watch for rapid weight gain, shortness of breath, or swelling. Tell your doctor right away if these appear. It should not be started if you have severe (Class III or IV) heart failure.

Lactic acidosis: Metformin can lead to a dangerous buildup of lactic acid. Early signs can be vague, such as feeling unwell, muscle aches, trouble breathing, unusual sleepiness, or stomach pain. Risk is higher with kidney or liver problems, age 65 or older, heavy alcohol use, contrast-dye imaging, surgery, low oxygen states, mitochondrial disease, and some other medicines. If you suspect it, stop the medicine and get hospital care right away.

Read the full warning on DailyMed →

Metformin / Pioglitazone by the Numbers

Strengths
2
in one form
Makers and packagers
6
Earliest FDA record
2005
Rank by Medicaid prescriptions
#1,154 of 1,682 drugs
More prescriptions than 31% of the 1,682 drugs we measure
3,108 prescriptions, Q1–Q4 2025

Patient Information Guide for Metformin / Pioglitazone

What It’s Used For

Metformin / Pioglitazone is a combination tablet used for one main purpose.

  • Improving blood sugar control in adults with type 2 diabetes, along with diet and exercise (Actoplus Met and the generic pioglitazone and metformin hydrochloride tablets).
  • It is not recommended for type 1 diabetes or diabetic ketoacidosis.

How It Works

Pioglitazone makes your body more responsive to insulin and lowers sugar released by the liver. It works through a receptor called PPAR-gamma found in fat, muscle and liver, and needs insulin to be present to work.

Metformin lowers liver sugar production, reduces sugar absorbed from the gut, and improves how muscles use sugar. It does not raise insulin levels.

Drug Class

Drug Class

  • Peroxisome Proliferator-activated Receptor alpha Agonist from pioglitazone
  • Peroxisome Proliferator-activated Receptor gamma Agonist from pioglitazone
  • Thiazolidinedione from pioglitazone
  • Biguanide from metformin
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Metformin / Pioglitazone has two active ingredients, so each class says which one it comes from.

Drug Class

Established Pharmacologic Class (EPC)
  • Peroxisome Proliferator-activated Receptor alpha Agonist from pioglitazone
  • Peroxisome Proliferator-activated Receptor gamma Agonist from pioglitazone
  • Thiazolidinedione from pioglitazone
  • Biguanide from metformin

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Peroxisome Proliferator-activated Receptor alpha Agonists from pioglitazone
  • Peroxisome Proliferator-activated Receptor gamma Agonists from pioglitazone

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Metformin / Pioglitazone in the FDA’s index.

From our Patient Information GuidePioglitazone makes your body more responsive to insulin and lowers sugar released by the liver. It works through a receptor called PPAR-gamma found in fat, muscle and liver, and needs insulin to be present to work. Metformin lowers liver sugar production, reduces sugar absorbed from the gut, and improves how muscles use sugar. Read How Metformin / Pioglitazone Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Thiazolidinediones from pioglitazone
  • Biguanides from metformin

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Combinations of oral blood glucose lowering drugs

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

These tablets are taken by mouth with meals to ease stomach side effects. Your prescriber individualizes your starting dose and raises it gradually based on response and tolerability.

  • Liver tests and kidney function (eGFR) should be checked before you start.
  • If you miss a dose, do not double the next one.
  • Follow your prescriber and your label for the exact dose.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Not treated with either pioglitazone or metformin hydrochloride, starting dosage

For adults not taking pioglitazone or metformin · Starting dose
Dose 15 mg of pioglitazone
  • One tablet (15 mg of pioglitazone and 850 mg of metformin hydrochloride per tablet) orally once daily

Currently treated with metformin hydrochloride, starting dosage

For adults already taking metformin · Starting dose
Dose 15 mg of pioglitazone
  • One tablet (15 mg of pioglitazone and 850 mg of metformin hydrochloride per tablet) orally once or twice daily.
  • Select a dosage that is as close as possible to the current dosage of metformin hydrochloride

Currently treated with pioglitazone, starting dosage

For adults already taking pioglitazone · Starting dose
Dose 15 mg of pioglitazone
  • One tablet (15 mg of pioglitazone and 850 mg of metformin hydrochloride per tablet) orally once daily

Currently treated with pioglitazone and metformin hydrochloride, starting dosage

For adults already taking pioglitazone and metformin · Starting dose
Usual dose 15 mg of pioglitazone
  • Select a dosage that is as close as possible to the current dosage of pioglitazone and metformin hydrochloride while not exceeding three tablets orally per day (15 mg of pioglitazone and 850 mg of metformin hydrochloride per tablet)

Also three tablets orally per day

Needing additional glycemic control, dosage titration

For adults · Dose increase
Dose 45 mg of pioglitazone Highest dose 45 mg of pioglitazone a day

Step by step

  1. Titrate gradually, as needed, after assessing therapeutic response and tolerability
  2. May be increased to three tablets per day (45 mg of pioglitazone and 2,550 mg of metformin hydrochloride)
  3. Total daily dosages of 2,550 mg of metformin hydrochloride may be taken in divided doses three times a day
  4. three tablets per day (45 mg of pioglitazone and 2,550 mg of metformin hydrochloride)

Good to know

Divided doses three times a day may reduce gastrointestinal adverse reactions

NYHA class I or II congestive heart failure, starting dosage

For adults · Starting dose
Starting dose 15 mg of pioglitazone and 500 mg of metformin, or 15 mg of pioglitazone and 850 mg of metformin, once a day

Good to know

Monitor for fluid retention after initiation and dose increases

Type 2 diabetes (blood sugar control)

For adults also taking gemfibrozil or similar strong CYP2C8 inhibitors
Dose 15 mg of pioglitazone Highest dose 15 mg of pioglitazone a day
  • One tablet (15 mg of pioglitazone and 850 mg of metformin hydrochloride) once daily

Limit one tablet (15 mg of pioglitazone and 850 mg of metformin hydrochloride) once daily

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects reported are:

Common side effects

  • Upper respiratory tract infection (cold-like symptoms)
  • Swelling (edema)
  • Diarrhea
  • Headache
  • Weight gain
  • Sinus infection
  • Muscle pain
  • Sore throat

When to get medical help

  • Rapid weight gain, shortness of breath, or swelling, which can be signs of heart failure
  • Unusual muscle pain, weakness, feeling very tired, trouble breathing, unusual sleepiness, or stomach pain, which can signal lactic acidosis (a dangerous buildup of lactic acid). Stop the medicine and get medical help right away
  • Fatigue, poor appetite, pain in the upper right belly, dark urine, or yellowing of the skin or eyes, which can signal liver problems
  • Sudden vision changes, which can signal macular edema (swelling in the back of the eye)
  • Blood in your urine or other bladder symptoms, since bladder cancer risk has been raised as a concern
  • Signs of low blood sugar if you also take insulin or a sulfonylurea
  • Bone fractures, which are more common in women taking pioglitazone

Warnings and Precautions

  • Heart failure: pioglitazone can cause fluid retention that causes or worsens heart failure. Watch for fast weight gain, shortness of breath, and swelling.
  • Lactic acidosis: metformin can cause this dangerous buildup, especially with kidney problems, liver disease, age 65 or older, heavy alcohol use, or low oxygen states.
  • Liver effects: liver failure, sometimes fatal, has been reported with pioglitazone. Liver tests are checked before starting.
  • Bladder cancer: it may raise the risk. Do not use with active bladder cancer.
  • Fractures: more common in women.
  • Macular edema: regular eye exams are recommended.
  • Vitamin B12: metformin may lower levels, so blood is checked periodically.
  • Contrast dye and surgery: the medicine may need to be paused.

Interactions

Several medicines and substances can change how this tablet works or raise its risks.

  • Gemfibrozil (strong CYP2C8 inhibitor): raises pioglitazone levels, so the dose is limited.
  • Rifampin: may lower pioglitazone levels.
  • Topiramate and other carbonic anhydrase inhibitors: may raise lactic acidosis risk.
  • Ranolazine, vandetanib, dolutegravir, cimetidine: can cause metformin to accumulate.
  • Alcohol: raises lactic acidosis risk.
  • Insulin or sulfonylureas: raise low blood sugar risk.
  • Steroids, thiazide diuretics, estrogens and others: can raise blood sugar.

Interactions Listed in the FDA-Approved Label

From the Metformin / Pioglitazone prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Strong CYP2C8 inhibitors For example: gemfibrozil
    What happensSignificantly increase pioglitazone exposure (AUC) and half-life.
    What to doLimit to 15 mg of pioglitazone and 850 mg of metformin HCl once daily.
  • CYP2C8 inducers For example: rifampin
    What happensMay significantly decrease pioglitazone exposure (AUC).
    What to doIf an inducer is started or stopped, changes in diabetes treatment may be needed based on clinical response, without exceeding 45 mg of pioglitazone and 2,550 mg of metformin HCl.
  • Carbonic anhydrase inhibitors (topiramate, zonisamide, acetazolamide, dichlorphenamide)
    What happensFrequently decrease serum bicarbonate and may increase the risk of lactic acidosis.
    What to doConsider more frequent monitoring.
  • Drugs that reduce metformin clearance (ranolazine, vandetanib, dolutegravir, cimetidine)
    What happensCould increase systemic exposure to metformin and may increase the risk of lactic acidosis.
    What to doConsider the benefits and risks of concomitant use.
  • Alcohol
    What happensPotentiates the effect of metformin on lactate metabolism.
    What to doWarn patients against excessive alcohol intake.
  • Insulin secretagogues (e.g., sulfonylurea) or insulin
    What happensMay increase the risk of hypoglycemia.
    What to doIf hypoglycemia occurs with an insulin secretagogue, reduce the dose of the insulin secretagogue.
  • Drugs affecting glycemic control (thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, isoniazid)
    What happensTend to produce hyperglycemia and may lead to loss of glycemic control.
    What to doObserve closely for loss of blood glucose control when given; observe closely for hypoglycemia when withdrawn.
  • What happensDecreases exposure of pioglitazone and its active metabolites; clinical relevance unknown.
    What to doMonitor patients for adequate glycemic control.
Read the label’s full interactions text

7 DRUG INTERACTIONS • Strong CYP2C8 inhibitors (e.g., gemfibrozil): Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. • CYP2C8 inducers (e.g., rifampin) may decrease pioglitazone concentrations. • Carbonic anhydrase inhibitors may increase risk of lactic acidosis. Consider more frequent monitoring. • Drugs that reduce metformin clearance (such as ranolazine, vandetanib, dolutegravir, and cimetidine), may increase the accumulation of metformin. Consider the benefits and risks of concomitant use. • Alcohol: Warn patients against excessive alcohol intake. • Use of insulin secretagogues or insulin use may increase the risk for hypoglycemia and may require dose reduction. • Topiramate may decrease pioglitazone concentrations. 7.1 Strong CYP2C8 Inhibitors An inhibitor of CYP2C8 (e.g., gemfibrozil) significantly increases the exposure (area under the serum concentration-time curve or AUC) and half-life (t 1/2 ) of pioglitazone. Therefore, the maximum recommended dosage of pioglitazone and metformin hydrochloride tablets is 15 mg of pioglitazone and 850 mg of metformin HCl once daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors. 7.2 CYP2C8 Inducers An inducer of CYP2C8 (e.g., rifampin) may significantly decrease the exposure (AUC) of pioglitazone. Therefore, if an inducer of CYP2C8 is started or stopped during treatment with pioglitazone and metformin hydrochloride tablets, changes in diabetes treatment may be needed based on clinical response without exceeding the maximum recommended daily dosage of pioglitazone and metformin hydrochloride tablets, (45 mg of pioglitazone and 2,550 mg of metformin HCl).

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Not for people with established Class III or IV heart failure, severe kidney impairment (eGFR below 30), metabolic acidosis, or a serious allergy to its ingredients.
  • Not recommended with symptomatic heart failure, liver disease, or mitochondrial disease.
  • Use caution with edema, or a history of bladder cancer.
  • Pregnancy: data are limited. Tell your doctor if you are pregnant or planning pregnancy. It may cause ovulation in some women who were not ovulating.
  • Breastfeeding: metformin is present in human milk, so discuss with your doctor.
  • Children: not recommended.
  • Older adults: kidney function should be checked more often.

Overdose

In metformin overdose, lactic acidosis occurred in about 32% of cases, and low blood sugar was reported in about 10%. Hemodialysis may help remove metformin. If you suspect an overdose, call Poison Help at 1-800-222-1222 or seek emergency care.

How Your Body Processes It

The combination tablet delivers pioglitazone and metformin at levels equivalent to taking them separately. Food slightly delays absorption, but this is not likely to matter clinically. Pioglitazone is heavily metabolized by the liver and mostly leaves through bile and stool. Metformin is not metabolized and is cleared unchanged by the kidneys, which is why kidney problems raise the risk of buildup.

Storage

Store at 20º to 25º C (68º to 77º F); excursions permitted to 15º to 30º C (59º to 86º F) . Protect from moisture and humidity.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Metformin / Pioglitazone: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Metformin / Pioglitazone — the kind of thing our pharmacy team would talk through with you at the counter.

What is this medicine for?

It helps lower blood sugar in adults with type 2 diabetes, along with diet and exercise. It combines two medicines that work in different ways. It is not meant for type 1 diabetes.

How should I take it?

Take it by mouth with meals, which helps reduce stomach upset from the metformin. If you miss a dose, just take your next one on schedule and don't double up. Follow your prescriber's directions and the label.

What side effects should I expect?

Common ones include cold-like symptoms, swelling, diarrhea, headache, and weight gain. Taking it with food may ease stomach effects. Call your doctor if the swelling or weight gain happens quickly.

When should I get help right away?

Get help if you have fast weight gain, shortness of breath, or swelling, which can mean heart failure. Also seek care for unusual muscle pain, weakness, trouble breathing, unusual sleepiness, or stomach pain, which can signal lactic acidosis. Stop the medicine in that case. Yellow skin or eyes, dark urine, or sudden vision changes also need prompt attention.

Can I drink alcohol while taking it?

Heavy drinking raises your risk of lactic acidosis, so avoid excessive alcohol. Talk with your doctor about what is safe for you.

Is it safe in pregnancy?

There isn't enough data to know the risk to a pregnancy. This medicine may also cause ovulation in some women who were not ovulating, so pregnancy is possible. Tell your doctor if you are pregnant, planning to be, or breastfeeding.

Is metformin / pioglitazone available over the counter?

No. Metformin / pioglitazone is a prescription medicine: every metformin / pioglitazone product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was metformin / pioglitazone first available?

The earliest FDA record we hold for metformin / pioglitazone is from 2005: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when metformin / pioglitazone was first used.

Who makes metformin / pioglitazone?

6 companies currently list metformin / pioglitazone products in the FDA's NDC Directory, including Bryant Ranch Prepack, Aurobindo Pharma Limited, Macleods Pharmaceuticals Limited. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of metformin / pioglitazone?

Metformin / pioglitazone is the generic name. Its brand names are Actoplus Met and Actoplus Met XR. Generic versions are listed under the name metformin / pioglitazone.

What is the generic name of Actoplus Met?

The generic name of Actoplus Met is metformin / pioglitazone. A generic name is the name of the active ingredients, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is metformin / pioglitazone?

Metformin / pioglitazone belongs to the drug class Biguanide, Peroxisome Proliferator-activated Receptor alpha Agonist, Peroxisome Proliferator-activated Receptor gamma Agonist and Thiazolidinedione, its established pharmacologic class on the FDA label.

Is there a generic version of metformin / pioglitazone?

Yes. FDA-approved generic versions of metformin / pioglitazone are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does metformin / pioglitazone come in?

Metformin / pioglitazone is listed in the FDA's National Drug Code Directory in these forms and strengths. Tablet (by mouth): 500 mg/15 mg and 850 mg/15 mg. A listing does not mean every pharmacy stocks every strength.

How much does metformin / pioglitazone cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $0.24 to $0.32 per generic tablet across 4 strengths as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Where can I read the metformin / pioglitazone prescribing information (package insert)?

The full FDA-approved prescribing information for metformin / pioglitazone, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Takeda Pharmaceuticals America, Inc.'s, revised Aug 21, 2026, and links to it on DailyMed.

Is metformin / pioglitazone gluten free?

No metformin / pioglitazone label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten, and none names a starch, dextrin or maltodextrin without saying where it comes from. We read the FDA labels of 13 metformin / pioglitazone products from 6 companies. A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's metformin / pioglitazone by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See metformin / pioglitazone inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Metformin / Pioglitazone

Skip the scrolling. Ask in your own words and get an answer from Metformin / Pioglitazone’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Metformin / Pioglitazone’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Metformin / Pioglitazone on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, usually within a day.
Detailed Data & References for Metformin / Pioglitazone Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Metformin / Pioglitazone Forms and Strengths (How It Comes)

Metformin / Pioglitazone comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Metformin / Pioglitazone inactive ingredients by manufacturer.

Tablet

By mouth
Brands Actoplus Met (the first brand, 2005) Actoplus Met XR (2009)
How this form is used
What it may be used for
  • Actoplus Met is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
  • Pioglitazone and metformin hydrochloride tablets are used the same way and are not for type 1 diabetes or diabetic ketoacidosis.
Important instructions
  • Actoplus Met is taken by mouth with meals to reduce stomach side effects from metformin.
  • Actoplus Met: if you miss a dose, do not double the next dose.
  • Pioglitazone and metformin hydrochloride tablets are also taken by mouth with meals, after liver tests are checked.
Available strengths 2 strengths
14 FDA-listed product records ⓘ

Metformin / Pioglitazone on the U.S. Market: Products, Makers and Brands

How Metformin / Pioglitazone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

6 companies list 13 Metformin / Pioglitazone product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2005. Brand names in the directory today include Actoplus Met and Actoplus Met XR; the rest are generics.

1
Dose forms ⓘ
6
Labelers (makers, repackagers, distributors)
2
Brand names ⓘ
13
FDA-listed product records ⓘ
2005
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Unfinished tablet (2) · Unfinished tablet, film coated (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

Bryant Ranch Prepack31%
Aurobindo Pharma Limited15%
Macleods Pharmaceuticals Limited15%
Rising Pharma Holdings, Inc.15%
Torrent Pharmaceuticals Limited15%
Takeda Pharmaceuticals America, Inc.8%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Metformin / Pioglitazone Is Used (Medicaid Data)

How many Metformin / Pioglitazone prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

3,108
Medicaid prescriptions filled (Q1–Q4 2025)
$117,964 paid by Medicaid, before rebates

How commonly is Metformin / Pioglitazone prescribed? Of the 1,682 medications we measure, Metformin / Pioglitazone ranks #1,154 by Medicaid prescriptions — more than 31% of them.

Where Metformin / Pioglitazone ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Metformin / Pioglitazone product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 850 mg / 15 mg oral tablet is the most-dispensed Metformin / Pioglitazone product — about 71% of these Medicaid prescriptions.

metformin hydrochloride 850 MG / pioglitazone 15 MG Oral Tablet Most dispensed

2,208 Medicaid prescriptions (Q1–Q4 2025) 71% of Metformin / Pioglitazone prescriptions shown $72,601 paid by Medicaid, before rebates ≈ $33 per prescription, before rebates

6 of 27 listed NDCs had Medicaid claims. RxNorm 861822

metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet

900 Medicaid prescriptions (Q1–Q4 2025) 29% of Metformin / Pioglitazone prescriptions shown $45,364 paid by Medicaid, before rebates ≈ $50 per prescription, before rebates

3 of 28 listed NDCs had Medicaid claims. RxNorm 861783

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 9 of the 55 listed Metformin / Pioglitazone NDCs had Medicaid claims.

Compare Metformin / Pioglitazone Products

A representative set of FDA-listed product records for Metformin / Pioglitazone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Tablet
PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 500 mg Oral Aurobindo Pharma Limited ANDA View NDC →
PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 850 mg Oral Aurobindo Pharma Limited ANDA View NDC →
PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 500 mg Oral Bryant Ranch Prepack × 2 listings ANDA View NDC →
PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 850 mg Oral Bryant Ranch Prepack × 2 listings ANDA View NDC →
METFORMIN HYDROCHLORIDE 500 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg Oral Macleods Pharmaceuticals Limited ANDA View NDC →
METFORMIN HYDROCHLORIDE 850 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg Oral Macleods Pharmaceuticals Limited ANDA View NDC →
PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 500 mg Oral Rising Pharma Holdings, Inc. ANDA View NDC →
PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 850 mg Oral Rising Pharma Holdings, Inc. ANDA View NDC →
PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 850 mg Oral Takeda Pharmaceuticals America, Inc. NDA View NDC →
METFORMIN HYDROCHLORIDE 500 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg Oral Torrent Pharmaceuticals Limited ANDA View NDC →
METFORMIN HYDROCHLORIDE 850 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg Oral Torrent Pharmaceuticals Limited ANDA View NDC →

Showing 13 of 13 products — FDA National Drug Code Directory. See every product, package size and price: browse all 13 Metformin / Pioglitazone NDCs →

Metformin / Pioglitazone Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Metformin / Pioglitazone recalls since July 2021.

✅No Metformin / Pioglitazone recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Metformin / Pioglitazone in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.

Dose forms
1
Strengths
2
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Multiple ingredients (MIN) Metformin / Pioglitazone RxCUI 607999
  1. Dose form (SCDF) Oral Tablet RxCUI 577093
    In current FDA listings

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Metformin / Pioglitazone Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Metformin / Pioglitazone: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

How the Pharmacy Price Has Changed

Pick a strength to see how its price has changed since Nov 2023.

Strength

For the generic PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 500 mg tablet, pharmacies paid an average of $0.317 per tablet as of Nov 18, 2026, down 24% from $0.415 a year earlier.

What pharmacies pay now
$0.317
per tablet, as of Nov 18, 2026
Last 4 weeks
Up 7.7%
from $0.294 on Oct 21, 2026
Last 12 months
Down 24%
from $0.415 on Nov 19, 2025
Lowest and highest since Nov 2023
$0.209 to $0.676
per tablet

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 500 mg tablet: the average pharmacy price per tablet, the last survey of each month
MonthPharmacy price
Nov 2026$0.317
Oct 2026$0.294
Sep 2026$0.284
Aug 2026$0.322
Jul 2026$0.377
Jun 2026$0.411
May 2026$0.410
Apr 2026$0.382
Mar 2026$0.383
Feb 2026$0.377
Jan 2026$0.397
Dec 2025$0.410
Nov 2025$0.415
Oct 2025$0.446
Sep 2025$0.514
Aug 2025$0.567
Jul 2025$0.538
Jun 2025$0.498
May 2025$0.492
Apr 2025$0.559
Mar 2025$0.556
Feb 2025$0.537
Jan 2025$0.538
Dec 2024$0.598
Nov 2024$0.631
Oct 2024$0.676
Sep 2024$0.618
Aug 2024$0.416
Jul 2024$0.320
Jun 2024$0.209
May 2024$0.307
Apr 2024$0.412
Mar 2024$0.230
Feb 2024$0.230
Jan 2024$0.230
Dec 2023$0.220
Nov 2023$0.612
FormStrengthVersion What pharmacies pay
Tablet · Oral PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 500 mg Generic $0.317 per tablet NDC details & price history
Tablet · Oral PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 850 mg Generic $0.239 per tablet NDC details & price history
Tablet · Oral METFORMIN HYDROCHLORIDE 500 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg Generic $0.317 per tablet NDC details & price history
Tablet · Oral METFORMIN HYDROCHLORIDE 850 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg Generic $0.239 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Metformin / Pioglitazone Brand Names

Metformin / Pioglitazone has 2 brand names on record: Actoplus Met and Actoplus Met XR. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Actoplus Met the first brand, 2005 Actoplus Met XR 2009

Who Makes Metformin / Pioglitazone: Manufacturers and Labelers

6 companies list Metformin / Pioglitazone products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, Aurobindo Pharma Limited, Macleods Pharmaceuticals Limited. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Bryant Ranch Prepack 4 Aurobindo Pharma Limited 2 Macleods Pharmaceuticals Limited 2 Rising Pharma Holdings, Inc. 2 Torrent Pharmaceuticals Limited 2 Takeda Pharmaceuticals America, Inc. 1

Sources for This Metformin / Pioglitazone Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Aug 21, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Metformin / Pioglitazone.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 9 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
9
Finished products in the current FDA directory
13
Companies listing them (makers, repackagers, distributors)
6
FDA labeler codes behind them ⓘ
7
Linked representative label ⓘ
Takeda Pharmaceuticals America, Inc.
Linked label effective
Aug 21, 2026
Composite sections available
24
Linked SPL Set ID
42e49120-6f3f-11db-9fe1-0800200c9a66
Linked SPL Document ID
8bacb433-92b6-4285-9ed3-b49e46ec63fc
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Takeda Pharmaceuticals America, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →